V.L. Talrose Institute for Energy Problems of Chemical Physics, Federal Research Center of Chemical Physics, Russian Academy of Sciences, Moscow, Russia.
Department of Chemistry, M. V. Lomonosov Moscow State University, Moscow, Russia.
Proteomics. 2023 Mar;23(5):e2200275. doi: 10.1002/pmic.202200275. Epub 2022 Dec 14.
Omics technologies focus on uncovering the complex nature of molecular mechanisms in cells and organisms, including biomarkers and drug targets discovery. Aiming at these tasks, we see that information extracted from omics data is still underused. In particular, characteristics of differentially regulated molecules can be combined in a single score to quantify the signaling pathway activity. Such a metric can be useful for comprehensive data interpretation to follow: (1) developing molecular responses in time; (2) potency of a drug on a certain cell culture; (3) ranking the signaling pathway activity in stimulated cells; and (4) integration of the omics data and assay-based measurements of cell viability, cytotoxicity, and proliferation. With recent advances in ultrafast mass spectrometry for quantitative proteomics allowing data collection in a few minutes, proteomics score for cellular response to stimuli can become a fast, accurate, and informative complement to bioassays. Here, we utilized an interquartile-based selection of differentially regulated features and a variety of schemes for quantifying cellular responses to come up with the quantitative metric for total cellular response and pathway activity. Validation was performed using antiproliferative and virus assays and label-free proteomics data collected for cancer cells subjected to drug stimulation.
组学技术专注于揭示细胞和生物体中分子机制的复杂性质,包括生物标志物和药物靶点的发现。针对这些任务,我们发现从组学数据中提取的信息仍然未得到充分利用。特别是,差异调节分子的特征可以组合在一个单一的分数中,以量化信号通路的活性。这种度量标准可用于综合数据解释,以跟踪:(1) 随时间发展的分子反应;(2) 药物对特定细胞培养物的效力;(3) 刺激细胞中信号通路活性的排序;(4) 组学数据和基于测定的细胞活力、细胞毒性和增殖的整合。随着用于定量蛋白质组学的超快质谱技术的最新进展,允许在几分钟内收集数据,细胞对刺激的反应的蛋白质组学评分可以成为生物测定的快速、准确和信息丰富的补充。在这里,我们利用基于四分位数的差异调节特征选择和多种量化细胞对刺激反应的方案,提出了总细胞反应和通路活性的定量度量标准。使用抗增殖和病毒测定以及针对接受药物刺激的癌细胞收集的无标记蛋白质组学数据进行了验证。